Nothing said here yet.
to join the conversation.
| Reis MischaSVP, Strategy & Bus. Dev. | Sell | 8,000 | $220.0K | Thu, Aug 20 |
NVST's Q3 earnings may have gained from Spark aligner growth, new product launches and improving margins. Can innovation drive another earnings beat?
Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BREA, Calif., Oct. 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2026 on Wednesday, November 4, 2026.
TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the “TCW Relative Value Mid Cap Fund”. The letter can be downloaded here.
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the dental equipment & technology industry, including Envista (NYSE:NVST) and its peers.
Envista Holdings (NVST) is set to present at the 2026 Global Healthcare Conference in New York on September 15, giving investors fresh commentary to weigh against recent share performance and fundamentals.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks.
Envista (NVST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it.
BREA, Calif., Sept. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2026 Global Healthcare Conference.
Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.